Showing results (151-160 of 326) with videos related to
Sort By:
Pageof 33
Journal of Athletic Training|June 29, 2021
An Evidence-Based Review of the Pathophysiology, Treatment, and Prevention of Exercise-Associated Muscle CrampsKevin C Miller, Brendon P McDermott, Susan W Yeargin, et al.Cancer|November 6, 2018
Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myelomaAjai Chari, Sagar Lonial, Tomer M Mark, et al.Advances in Therapy|February 21, 2020
Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic AnalysesXu Steven Xu, Philippe Moreau, Saad Z Usmani, et al.Annals of Hematology|February 18, 2021
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA studyShinsuke Iida, Takayuki Ishikawa, Chang Ki Min, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 16, 2017
BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing CommitteeSarah A Holstein, Hervé Avet-Loiseau, Theresa Hahn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2012
Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1Christoph J Heuck, Jackie Szymonifka, Emily Hansen, et al.Journal of Athletic Training|February 17, 2017
Validity of Core Temperature Measurements at 3 Rectal Depths During Rest, Exercise, Cold-Water Immersion, and RecoveryKevin C Miller, Lexie E Hughes, Blaine C Long, et al.Clinical Lymphoma, Myeloma & Leukemia|March 26, 2023
Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple MyelomaMaría-Victoria Mateos, Ajai Chari, Saad Z Usmani, et al.British Journal of Sports Medicine|December 11, 2012
Significant and serious dehydration does not affect skeletal muscle cramp threshold frequencyKyle W Braulick, Kevin C Miller, Jay M Albrecht, et al.Bone Marrow Transplantation|October 5, 2021
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysisOren Pasvolsky, Moshe Yeshurun, Raphael Fraser, et al.Pageof 33